|
05 May 2007 |
PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
|
|
04 May 2007 |
Biovitrum Initiates Phase II Clinical Trial of Novel Pain Treatment
|
|
04 May 2007 |
Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease
|
|
04 May 2007 |
Sequella Lead Drug SQ109 Completes Phase 1a Trial
|
|
04 May 2007 |
Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520
|
|
04 May 2007 |
ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
|
|
04 May 2007 |
Incyte Reviews Progress in Multiple Drug Development Programs and Announces First Quarter 2007 Financial Results
|
|
04 May 2007 |
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
|
|
04 May 2007 |
Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-TRAMADOL ER
|
|
04 May 2007 |
IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Today Announced Positive Results From a First Pilot Pharmacokinetic (PK) Study On QuitPak (INT003/05)
|
|
04 May 2007 |
First patient enrolled in phase II study of BF-37 in atopic dermatitis
|
|
04 May 2007 |
Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
|
|
04 May 2007 |
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
|
|
04 May 2007 |
Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid
|
|
04 May 2007 |
CyDex Licenses Captisol(R) to Sunesis Pharmaceuticals for Oncology Drug Candidate
|
|
03 May 2007 |
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
|
|
03 May 2007 |
Phase III Data on Safinamide in Parkinson's Disease Presented at American Academy of Neurology 59th Annual Meeting
|
|
03 May 2007 |
Spectrum Pharmaceuticals Initiates Phase 3, Registrational Trials With EOquin(R) in Non-Invasive Bladder Cancer
|
|
03 May 2007 |
Last Patient Treated in First Pivotal TH9507 Study
|
|
03 May 2007 |
BioMarin Initiates Phase 2a Clinical Study of 6R-BH4 in Sickle Cell Disease
|
|
03 May 2007 |
FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
|
|
03 May 2007 |
Sunesis Pharmaceuticals Announces Preclinical Milestone Payment in BACE Collaboration with Merck
|
|
03 May 2007 |
Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model
|
|
03 May 2007 |
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
|
|
03 May 2007 |
Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
|
